Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Inhaled Medications01:23

Inhaled Medications

315
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
315
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

310
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
310
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lower plasma resolvin D1 level and greater sputum eosinophilia characterize a cluster of severe asthma patients.

Respiratory research·2026
Same author

Community perspectives on the return of research results and ownership of data and specimens for brain tumor genomic research.

SSM. Qualitative research in health·2026
Same author

A cross-sectional study of oxidative stress pathway genotypes and their interactions with environmental pollutant levels identifies associations with gene expression and lung function.

EBioMedicine·2026
Same author

Dupilumab sustains efficacy despite LABA and ICS withdrawal in patients with asthma: A post hoc analysis.

The journal of allergy and clinical immunology. In practice·2026
Same author

Clinical phenotyping improves choices of biologics in asthma - Authors' reply.

Lancet (London, England)·2026
Same author

Bronchial thermoplasty for severe asthma: Systematic review and meta-analysis of benefits and harms.

The journal of allergy and clinical immunology. Global·2026

Related Experiment Video

Updated: Jul 23, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K

What Patients Call Their Inhalers Is Associated with "Asthma Attacks".

Victoria E Forth1, Juan Carlos Cardet1, Ku-Lang Chang1

  • 1From the Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA (VEF, BE, NEM, EI, PAH, JK, JRL, JC, JDS); Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida, Morsani College of Medicine, Tampa, FL (JCC); Denver Health and Hospital Authority, Denver, CO (LPH); Lucas Research, Morehead City, NC (KLC); American Academy of Family Physicians National Research Network, Leawood, KS (EWS, JKC, BKM, WDP, JBS); University of Colorado Department of Family Medicine, Aurora, CO (EWS, JKC); Department of Internal Medicine, Allergy/Immunology Section, University of Puerto Rico, San Juan, PR (BTS); Division of Allergy and Immunology, Brigham and Women's Hospital, Boston, MA (EI); Pulmonary Science and Critical Care Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO (ALF); DARTNet Institute, Aurora, CO (WDP); Division of Immunology, Boston Children's Hospital, Boston, MA (WP); University of Miami Health System, Miami, FL (MF); Division of Allergy and Immunology, Department of Medicine, NorthShore University Health System, Glenview, IL (GM); Morehouse School of Medicine, Atlanta, GA (FO).

Journal of the American Board of Family Medicine : JABFM
|July 19, 2023
PubMed
Summary

Patients using non-standard asthma inhaler names face higher risks of severe asthma attacks and hospitalizations. Identifying these non-standard names can help pinpoint individuals needing more support for better asthma management.

Keywords:
AsthmaHealth LiteracyInhalersOutcomes AssessmentPhysician-Patient Relations

More Related Videos

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.7K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

3.6K

Related Experiment Videos

Last Updated: Jul 23, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.7K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

3.6K

Area of Science:

  • Respiratory Medicine
  • Clinical Epidemiology
  • Health Communication

Background:

  • Clinician-patient miscommunication negatively impacts asthma outcomes.
  • The terminology patients use for asthma inhalers and its link to disease severity are not well understood.

Purpose of the Study:

  • To investigate the relationship between the names patients use for their asthma inhalers and asthma-related morbidity.
  • To determine if non-standard inhaler nomenclature is associated with increased asthma exacerbations and healthcare utilization.

Main Methods:

  • Inhaler names were collected from Black and Latinx adults with moderate-to-severe asthma and classified as standard (brand/generic/type) or non-standard (color/device/unique names).
  • Asthma morbidity, including systemic corticosteroid bursts, emergency department (ED)/urgent care (UC) visits, hospitalizations, asthma control, and quality of life, were assessed.
  • Multivariable regression models were employed to analyze the association between non-standard inhaler names and asthma morbidity.

Main Results:

  • Nearly half (44%) of participants used non-standard inhaler names, with these individuals being more likely to be Black and from the Southeast.
  • Use of non-standard inhaler names was significantly associated with increased rates of corticosteroid bursts (IRR=1.29), ED/UC visits (IRR=1.43), and hospitalizations (OR=1.57) for asthma.
  • Participants using non-standard names reported more asthma exacerbations compared to those using standard names.

Conclusions:

  • Patients who refer to their asthma inhalers using non-standard terms experience greater asthma morbidity.
  • Assessing the names patients use for their inhalers may serve as a rapid screening tool to identify high-risk individuals for improved asthma care.